Spots Global Cancer Trial Database for adriamycin
Every month we try and update this database with for adriamycin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| PAD Combination Therapy Followed by Thal/Dex for Relapsed or Refractory Multiple Myeloma | NCT00319865 | Multiple Myelom... | Velcade Thalidomide Adriamycin Dexamethasone | 0 Years - 75 Years | Korean Multiple Myeloma Working Party | |
| Neoadjuvant Adriamycin and Ifosfamide Plus High-Dose ICE in Patients With Soft Tissue Sarcoma (STS) | NCT00204646 | Sarcoma, Soft T... | Adriamycin Ifosfamide Etoposide Carboplatin | 18 Years - 65 Years | University Hospital Tuebingen | |
| Molecular Triaging of Newly Diagnosed Breast Cancer | NCT01159236 | Breast Cancer | Paclitaxel Fluorouracil Doxorubicin Epirubicin Cyclophosphamid... Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | NCT00500422 | Solid Tumors | Doxil Gemcitabine Velcade | - | M.D. Anderson Cancer Center | |
| Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | NCT00500422 | Solid Tumors | Doxil Gemcitabine Velcade | - | M.D. Anderson Cancer Center | |
| Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | NCT01404936 | Lymphoma | Interferon-2A Adriamycin Bleomycin Velban Dacarbazine | - | M.D. Anderson Cancer Center | |
| Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) | NCT00215943 | Multiple Myelom... | zoledronic acid dexamethasone thalidomide vincristine adriamycin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| Study of a-Interferon With Adriamycin, Bleomycin, Velban, and Dacarbazine (ABVD) With Hodgkin's Disease | NCT01404936 | Lymphoma | Interferon-2A Adriamycin Bleomycin Velban Dacarbazine | - | M.D. Anderson Cancer Center | |
| Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | NCT02881086 | Acute Lymphobla... Lymphoblastic L... | Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone | 18 Years - 55 Years | Goethe University | |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult T-LBL/ALL | NCT03564704 | Leukemia Leukemia, Acute Adult Lymphobla... Leukemia, Lymph... Leukemia, T Cel... Adult Acute Lym... Lymphoblastic L... Lymphoblastic L... | Dexamethasone vincristine Cyclophosphamid... Idarubicin Pegaspargase Adriamycin Methotrexate 6-mercaptopurin... Etoposide Cytarabine Bone marrow asp... Intrathecal inj... Radiation thera... NGS allogeneic hema... Flow-MRD FISH Flow immunophen... Karyotyping Chidamide PET-CT scan | 14 Years - 55 Years | Nanfang Hospital, Southern Medical University | |
| Combination Chemotherapy (FLAC) Combined With Granulocyte-Macrophage Colony Stimulating Factor in Locally Advanced and Metastatic Breast Cancer | NCT00001239 | Breast Cancer Breast Neoplasm... | FLAC with GM-CS... | - | National Institutes of Health Clinical Center (CC) | |
| HD10 for Early Stages | NCT00265018 | Hodgkin´s Lymph... | Adriamycin Bleomycin Vinblastine DTIC 30 Gy IF-RT 20 Gy IF-RT | 16 Years - 75 Years | University of Cologne | |
| Primary Breast Cancer Occurring Concomitant With Pregnancy | NCT00510367 | Breast Cancer Pregnancy | 5-Fluorouracil Cyclophosphamid... Doxorubicin | - | M.D. Anderson Cancer Center | |
| Camrelizumab Plus Doxorubicin for the First Line Treatment of Adcanced Soft Tissue Sarcoma | NCT04910126 | Soft Tissue Sar... Neoplasms, Conn... Sarcoma Metasta... Sarcoma,Soft Ti... | Camrelizumab Adriamycin | 18 Years - 60 Years | Wuhan Union Hospital, China | |
| Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient | NCT00669773 | Breast Cancer | Adriamycin Docetaxel | 18 Years - | National University Hospital, Singapore | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | NCT00136539 | Breast Cancer | Herceptin Taxol Adriamycin Cytoxan | 18 Years - | Dana-Farber Cancer Institute | |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
| Very Early PET-response Adapted Targeted Therapy for Advanced Hodgkin Lymphoma: a Single -Arm Phase II Study | NCT03517137 | Advanced Hodgki... | Brentuximab Ved... Adriamycin Vinblastine Dacarbazine Etoposide Cyclophosphamid... Radiation Thera... | 18 Years - 60 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Optimization of Therapy in Adult Patients With Newly Diagnosed Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma by Individualised, Targeted and Intensified Treatment | NCT02881086 | Acute Lymphobla... Lymphoblastic L... | Rituximab Nelarabine PEG-Asparaginas... Cranial irradia... Imatinib Idarubicin Dexamethasone Cyclophosphamid... Fludarabine Vincristine Mercaptopurine VP16 Daunorubicin (D... Methotrexate Stem cell trans... Cytarabine Vindesine Adriamycin Prednisolone | 18 Years - 55 Years | Goethe University | |
| Combination Chemotherapy in Treating Women With Stage IIIB or Stage IV Breast Cancer | NCT00003352 | Breast Cancer | cyclophosphamid... Taxotere Adriamycin | 18 Years - | NSABP Foundation Inc | |
| Brentuximab Vedotin as Consolidation Treatment in Patients With Stage I/II HL and PET Positivity After 2 Cycles of ABVD | NCT02298283 | Hodgkin Lymphom... | brentuximab ved... Cyclophosphamid... Adriamycin Oncovin Bleomycin Etoposide Procarbazine Prednisone G-CSF 30 Grays | 18 Years - 65 Years | The Lymphoma Academic Research Organisation | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| Doxil, Gemcitabine, and Velcade (PS341) in Advanced Cancer Patients | NCT00500422 | Solid Tumors | Doxil Gemcitabine Velcade | - | M.D. Anderson Cancer Center | |
| HD12 for Advanced Stages | NCT00265031 | Hodgkin´s Lymph... | Cyclophosphamid... Adriamycin Etoposide Procarbazine Prednisone Vincristine Bleomycin radiation thera... | 16 Years - 65 Years | University of Cologne | |
| Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | NCT00136539 | Breast Cancer | Herceptin Taxol Adriamycin Cytoxan | 18 Years - | Dana-Farber Cancer Institute | |
| Study With Trabectedin Versus Adriamycin Plus Dacarbazine, in Patients With Advanced Solitary Fibrous Tumor | NCT03023124 | Solitary Fibrou... | Trabectedin Adriamycin Dacarbazine | 18 Years - | Italian Sarcoma Group | |
| Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Inoperable Patients | NCT02099188 | Unresectable Si... | Cisplatin Docetaxel 5-fluorouracil Etoposide Adriamycin Ifosfamide Leucovorin Radiotherapy - ... Radiotherapy - ... Radiotherapy - ... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas | NCT00165139 | Neuroblastoma Ewings Sarcoma Non-rhabdomyosa... | Vincristine Cyclophosphamid... Adriamycin Etoposide (VP-1... Cisplatin Carboplatin Melphalan Ifosfamide G-CSF (granuloc... Mesna | - 19 Years | Dana-Farber Cancer Institute | |
| Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality-Obs | NCT04630275 | Hypogonadism | 18 Years - 65 Years | Herlev Hospital | ||
| Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer | NCT00107094 | Breast Cancer | Abraxane | 18 Years - 70 Years | Celgene Corporation | |
| Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 | NCT00004067 | Breast Cancer | herceptin adriamycin cyclophosphamid... taxol | 18 Years - | NSABP Foundation Inc | |
| A Safety Study Utilizing Yondelis and Doxorubicin in Patients With a Type of Cancer Called Soft Tissue Sarcoma | NCT00102609 | Soft Tissue Sar... Sarcoma Neoplasms, Conn... Neoplasms by Hi... Neoplasms | Doxorubicin Trabectedin Dexamethasone | 18 Years - | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | |
| Neoadjuvant Therapy With Herceptin and Taxol for Breast Cancer | NCT00136539 | Breast Cancer | Herceptin Taxol Adriamycin Cytoxan | 18 Years - | Dana-Farber Cancer Institute | |
| Comparison of Two Combination Chemotherapy Regimens in Treating Women With Breast Cancer | NCT00087178 | Breast Cancer | cyclophosphamid... adriamycin epirubicin fluorouracil | 18 Years - | NSABP Foundation Inc | |
| Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 | NCT00004067 | Breast Cancer | herceptin adriamycin cyclophosphamid... taxol | 18 Years - | NSABP Foundation Inc | |
| Study of Doxorubicin and Hyperthermic Intraperitoneal Chemotherapy (HIPEC) and Intraoperative Brachytherapy for Unresectable or Refractory Pelvic and Abdominal Rhabdomyosarcoma and Undifferentiated Sarcomas in Children | NCT03111069 | Malignant Neopl... Rhabdomyosarcom... Rhabdomyosarcom... | Abdominal Surge... Doxorubicin Intra-Operative... | 1 Year - 6 Years | M.D. Anderson Cancer Center | |
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation | NCT00083915 | Multiple Myelom... | Cisplatin Cyclophosphamid... Adriamycin Etoposide Melphalan Thalidomide Dexamethasone | 18 Years - | University of Arkansas | |
| Lenalidomide & Adriamycin & Dexamethasone (RAD) in Newly Diagnosed, Multiple Myeloma Patients | NCT02471820 | Multiple Myelom... | Lenalidomide Adriamycin Dexamethasone | 18 Years - 70 Years | University of Athens | |
| A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer | NCT02623972 | Inflammatory Br... Human Epidermal... | Eribulin Adriamycin Cyclophosphamid... | 18 Years - | Dana-Farber Cancer Institute | |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL | NCT03553238 | Leukemia, Acute Leukemia, T Cel... Leukemia, Lymph... | Chidamide Dexamethasone vincristine Cyclophosphamid... Idarubicin Pegaspargase Adriamycin Methotrexate 6-Mercaptopurin... Etoposide Cytarabine Bone marrow asp... Intrathecal inj... Radiation thera... NGS allogeneic hema... Flow-MRD FISH Flow immunophen... Karyotyping | 14 Years - 55 Years | Nanfang Hospital, Southern Medical University | |
| Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer | NCT03749850 | Metastatic Brea... Breast Cancer Breast Neoplasm... Stage IV Breast... Metastatic Canc... Invasive Ductal... Invasive Ductal... Adenocarcinoma ... | LTLD MR-HIFU induced... Cyclophosphamid... | 18 Years - | UMC Utrecht | |
| Precision Diagnosis Directing HDACi Chidamide Target Therapy for Adult ETP-ALL | NCT03553238 | Leukemia, Acute Leukemia, T Cel... Leukemia, Lymph... | Chidamide Dexamethasone vincristine Cyclophosphamid... Idarubicin Pegaspargase Adriamycin Methotrexate 6-Mercaptopurin... Etoposide Cytarabine Bone marrow asp... Intrathecal inj... Radiation thera... NGS allogeneic hema... Flow-MRD FISH Flow immunophen... Karyotyping | 14 Years - 55 Years | Nanfang Hospital, Southern Medical University | |
| Kinetics of Troponin and BNP in Breast Cancer Chemotherapy With Adriamycin and Trastuzumab | NCT01771549 | Breast Cancer | 18 Years - | Mayo Clinic | ||
| Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients | NCT02099175 | Sinonasal Tumor... | Cisplatin Docetaxel 5-fluorouracil Etoposide Adriamycin Ifosfamide Leucovorin Radiotherapy - ... Radiotherapy - ... Radiotherapy - ... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | NCT00083538 | Multiple Myelom... | Dexamethasone Thalidomide Cisplatinum Adriamycin Cyclophosphamid... Etoposide | 18 Years - | University of Arkansas | |
| Intensive Chemo-Radiotherapy With Peripheral Blood Progenitor Cell Rescue for Children With Advanced Neuroblastoma and Sarcomas | NCT00165139 | Neuroblastoma Ewings Sarcoma Non-rhabdomyosa... | Vincristine Cyclophosphamid... Adriamycin Etoposide (VP-1... Cisplatin Carboplatin Melphalan Ifosfamide G-CSF (granuloc... Mesna | - 19 Years | Dana-Farber Cancer Institute | |
| Alpha-Lipoic Acid in Breast Cancer Patients | NCT03908528 | Breast Cancer Chemotherapeuti... | Alpha-lipoic ac... Placebo Plus Ch... | 18 Years - 70 Years | Damanhour University | |
| Kinetics of Troponin and BNP in Breast Cancer Chemotherapy With Adriamycin and Trastuzumab | NCT01771549 | Breast Cancer | 18 Years - | Mayo Clinic | ||
| Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI) | NCT00410488 | Sarcoma Nausea Vomiting | Palonosetron - ... Palonosetron - ... Adriamycin Ifosfamide chem... Zinecard Mesna Vincristine Dexamethasone | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| DTPACE Followed by Tandem Transplant With Melphalan (MEL) 200 Versus MEL/Dexamethasone/Thalidomide (DT) Platinol/Adriamycin/Etoposide (PACE) Hybrid and DTPACE Consolidation | NCT00083915 | Multiple Myelom... | Cisplatin Cyclophosphamid... Adriamycin Etoposide Melphalan Thalidomide Dexamethasone | 18 Years - | University of Arkansas | |
| A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors | NCT03034304 | Advanced Solid ... | MASCT-I Ifosfamide PD1 antibody Adriamycin Gemcitabine Cisplatin Carboplatin | 18 Years - 70 Years | HRYZ Biotech Co. | |
| Aranesp and Neulasta in Patients With Sarcoma Receiving Adriamycin and Ifosfamide | NCT00283621 | Sarcoma | Aranesp (darbep... Neulasta (pegfi... Adriamycin Ifosfamide | 18 Years - 65 Years | M.D. Anderson Cancer Center | |
| Bortezomib With Gemcitabine/Doxorubicin in Patients With Urothelial Cancer and Other Solid Tumors | NCT00479128 | Solid Tumor Urethral Cancer | Bortezomib Gemcitabine Doxorubicin | - | M.D. Anderson Cancer Center | |
| Study of Tumor Antigen-Pulsed Autologous Dendritic Cell Vaccination Administrated Subcutaneously or Intranodally | NCT00083538 | Multiple Myelom... | Dexamethasone Thalidomide Cisplatinum Adriamycin Cyclophosphamid... Etoposide | 18 Years - | University of Arkansas | |
| Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality-Obs | NCT04630275 | Hypogonadism | 18 Years - 65 Years | Herlev Hospital | ||
| A Phase I Clinical Study for Evaluating the Safety and Efficacy of MASCT-I in Patients With Advanced Solid Tumors | NCT03034304 | Advanced Solid ... | MASCT-I Ifosfamide PD1 antibody Adriamycin Gemcitabine Cisplatin Carboplatin | 18 Years - 70 Years | HRYZ Biotech Co. | |
| Gonadal Dysfunction in Male Long-term Survivors of Malignant Lymphoma; Vitality-Obs | NCT04630275 | Hypogonadism | 18 Years - 65 Years | Herlev Hospital | ||
| Rituximab and ABVD for Hodgkin's Patients | NCT00504504 | Lymphoma | Rituximab Adriamycin Bleomycin Vinblastine Dacarbazine (DT... | 16 Years - | M.D. Anderson Cancer Center | |
| AMG 531 in Patients With Advanced Malignancy Receiving Treatment With Carboplatin | NCT00147225 | Solid Tumors Advanced Cancer | AMG 531 Carboplatin Adriamycin Ifosfamide | 18 Years - | M.D. Anderson Cancer Center | |
| Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma | NCT00578864 | Neuroblastoma | Protracted Oral... Doxorubicin IV Bolus Etopos... Cisplatin Cyclophosphamid... Mesna Hematopoietic F... Primary tumor r... | - | Baylor College of Medicine | |
| Molecular Triaging of Newly Diagnosed Breast Cancer | NCT01159236 | Breast Cancer | Paclitaxel Fluorouracil Doxorubicin Epirubicin Cyclophosphamid... Bevacizumab | 18 Years - | M.D. Anderson Cancer Center | |
| Intermittent G-CSF in Patients With Breast Cancer Receiving Adjuvant Docetaxel, Doxorubicin, and Cyclophosphamide (TAC) | NCT02685111 | Breast Cancer Neutropenia Febrile Neutrop... | Filgrastim Peg-filgrastim | 19 Years - 70 Years | Asan Medical Center | |
| Neoadjuvant Study of Sequential Eribulin Followed by FAC Compared to Sequential Paclitaxel Followed by FEC in Early Stage Breast Cancer Not Overexpressing HER-2 | NCT01593020 | Breast Cancer | Paclitaxel Eribulin 5-Fluorouracil Epirubicin Cyclophosphamid... Doxorubicin | 18 Years - | M.D. Anderson Cancer Center | |
| Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients | NCT00038142 | Ewing's Sarcoma | Vincristine Doxorubicin Cyclophosphamid... Dexrazoxane ImmTher | 3 Years - 60 Years | M.D. Anderson Cancer Center | |
| Multidisciplinary Approach for Poor Prognosis Sinonasal Tumors in Operable Patients | NCT02099175 | Sinonasal Tumor... | Cisplatin Docetaxel 5-fluorouracil Etoposide Adriamycin Ifosfamide Leucovorin Radiotherapy - ... Radiotherapy - ... Radiotherapy - ... | 18 Years - | Fondazione IRCCS Istituto Nazionale dei Tumori, Milano | |
| Primary Breast Cancer Occurring Concomitant With Pregnancy | NCT00510367 | Breast Cancer Pregnancy | 5-Fluorouracil Cyclophosphamid... Doxorubicin | - | M.D. Anderson Cancer Center | |
| Phase III Randomized Trial of Thalidomide/Dexamethasone Versus Vincristine+Adriamycin+Dexamethasone (VAD) | NCT00215943 | Multiple Myelom... | zoledronic acid dexamethasone thalidomide vincristine adriamycin | 18 Years - | H. Lee Moffitt Cancer Center and Research Institute | |
| HD11 for Intermediate Stages | NCT00264953 | Hodgkin´s Lymph... | Adriamycin Bleomycin Vinblastine DTIC Etoposide Procarbazine Prednisone Vincristine radiation thera... | 16 Years - 75 Years | University of Cologne | |
| Study of Adriamycin Plus Cyclophosphamide Followed by Abraxane as Adjuvant Therapy for Patients With Breast Cancer | NCT00107094 | Breast Cancer | Abraxane | 18 Years - 70 Years | Celgene Corporation | |
| Alpha-Lipoic Acid in Breast Cancer Patients | NCT03908528 | Breast Cancer Chemotherapeuti... | Alpha-lipoic ac... Placebo Plus Ch... | 18 Years - 70 Years | Damanhour University | |
| Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients | NCT00038142 | Ewing's Sarcoma | Vincristine Doxorubicin Cyclophosphamid... Dexrazoxane ImmTher | 3 Years - 60 Years | M.D. Anderson Cancer Center | |
| Brentuximab Vedotin Plus AD in Non-bulky Limited Stage Hodgkin Lymphoma | NCT02505269 | Hodgkin Lymphom... | Brentuximab Ved... Adriamycin Dacarbazine | 18 Years - | Massachusetts General Hospital | |
| A Pilot Trial of AC (Adriamycin, Cyclophosphamide) Chemotherapy With G-CSF (Granulocyte Colony-Stimulating Factor) Followed by Infusional Taxol (Paclitaxel) as Adjuvant Treatment for High Risk Stage II and Stage III Breast Cancer Patients | NCT00001384 | Breast Cancer Breast Neoplasm... | Adriamycin cyclophosphamid... G-CSF paclitaxel | - | National Institutes of Health Clinical Center (CC) | |
| Doxorubicin and Cyclophosphamide Plus Paclitaxel With or Without Trastuzumab in Treating Women With Node-Positive Breast Cancer That Overexpresses HER2 | NCT00004067 | Breast Cancer | herceptin adriamycin cyclophosphamid... taxol | 18 Years - | NSABP Foundation Inc | |
| Image-guided Targeted Doxorubicin Delivery With Hyperthermia to Optimize Loco-regional Control in Breast Cancer | NCT03749850 | Metastatic Brea... Breast Cancer Breast Neoplasm... Stage IV Breast... Metastatic Canc... Invasive Ductal... Invasive Ductal... Adenocarcinoma ... | LTLD MR-HIFU induced... Cyclophosphamid... | 18 Years - | UMC Utrecht | |
| Augmented Berlin-Frankfurt-Munster Therapy Plus Ofatumumab for Young Adults With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma | NCT02419469 | Leukemia Precursor-B Acu... Lymphoblastic L... Lymphoma | Cytarabine Daunorubicin Vincristine Prednisone PEG asparaginas... Ofatumumab Rituximab Methotrexate Cyclophosphamid... Mercaptopurine Doxorubicin Dexamethasone a... Thioguanine | 12 Years - 30 Years | M.D. Anderson Cancer Center | |
| OPTmizing Advanced Stage HodgkIn LymphoMa patIentS Therapy | NCT03527628 | Classical Hodgk... Hodgkin Lymphom... Hodgkin Disease Hodgkin Lymphom... | Adriamycin Cyclophosphamid... Vinblastine Dacarbazine Brentuximab Ved... ABVD | 14 Years - 60 Years | King Abdullah International Medical Research Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
